
C-Prio is a startup focused on revolutionizing cancer diagnosis and healthcare services through automation and AI technology, specifically addressing backlogs in NHS histopathology. Their flagship product, rAI-colon, is an AI tool designed for colorectal cancer diagnosis, providing precise diagnoses and supporting evidence for healthcare professionals. They also offer Dyna-PM, software that semi-automates post-mortem reports, saving over 50% of reporting time and reducing errors. Additionally, they leverage Axiomatic Process Tree Theory (APTT) for project risk assessment and innovation, which has been developed into a disruptive AI model for cancer diagnosis. C-Prio's vision is to enable harmonious collaboration between machines and humans in healthcare.

C-Prio is a startup focused on revolutionizing cancer diagnosis and healthcare services through automation and AI technology, specifically addressing backlogs in NHS histopathology. Their flagship product, rAI-colon, is an AI tool designed for colorectal cancer diagnosis, providing precise diagnoses and supporting evidence for healthcare professionals. They also offer Dyna-PM, software that semi-automates post-mortem reports, saving over 50% of reporting time and reducing errors. Additionally, they leverage Axiomatic Process Tree Theory (APTT) for project risk assessment and innovation, which has been developed into a disruptive AI model for cancer diagnosis. C-Prio's vision is to enable harmonious collaboration between machines and humans in healthcare.